Safety and Efficacy Study of L-FMAU in Chronic HBV Patients of L-FMAU-201 Placebo Group
NCT00313261 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2012-10-17
Summary
The purpose of this study is to evaluate the safety and antiviral activity of clevudine 30 mg QD for treatment of longer period (24 weeks) in patients chronically infected with HBV.
Conditions
Interventions
- DRUG
-
Clevudine
Sponsors & Collaborators
-
Bukwang Pharmaceutical
lead INDUSTRY
Principal Investigators
-
Hyo Suk Lee, M.D., Ph.D. · Seoul National University Hospital
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-06-30
- Completion
- 2005-02-28
Countries
- South Korea
Study Locations
More Related Trials
-
Long-term Study With Clevudine
NCT00558818 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Antiviral Activity of Clevudine in Patients Infected With Hepatitis B Virus
NCT00305019 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Efficacy Study of Clevudine Compared With Clevudine and Vaccine in Patient With HBeAg(+) Chronic HBV
NCT00501124 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Clevudine Plus Lamivudine for Lamivudine-resistant Chronic Hepatitis B Patients
NCT00798460 ·Status: TERMINATED ·Phase: PHASE4
-
A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis B
NCT01264133 ·Status: TERMINATED ·Phase: PHASE4
-
Switching Study From Lamivudine to Clevudine in the Chronic Hepatitis B Patients
NCT00558493 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy and the Change of sAg Levels in Chronic Hepatitis B Patients Receiving Clevudine Treatment Over the Long Period
NCT01264094 ·Status: TERMINATED ·Phase: PHASE4
-
An Open Study to Evaluate the Efficacy, Safety of Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis B
NCT01264354 ·Status: COMPLETED ·Phase: PHASE4
-
A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.
NCT00044135 ·Status: UNKNOWN ·Phase: PHASE2
-
A Double-Blind Randomized Clinical Trial Comparing the Safety and Antiviral Activity of 48-week Clevudine and Adefovir Dipivoxil in HBeAg(-) Chronic Hepatitis B With Compensated Liver Function
NCT00641082 ·Status: COMPLETED ·Phase: PHASE4
-
A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Proportion to Roadmap Concept in Patients With HBV Associated-HCC
NCT01263002 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy and Safety of Clevudine and Peg-interferon in Sequence Compared With Clevudine Alone in the Patients With HBeAg(+) Chronic Hepatitis B or Clevudine and Peg-interferon Sequential Treatment in Patients With Chronic Hepatitis B Who Have HBeAg(+)
NCT01264367 ·Status: COMPLETED ·Phase: PHASE4
-
ANRS HB 05 Multicenter Study Evaluating Efficacy and Safety of Clevudine Monotherapy Versus Tenofovir Monotherapy Versus Combination Therapy of Clevudine and Tenofovir for 96 Weeks in HBeAg Negative Patients With Chronic Hepatitis B, naïve to Anti-VHB Therapy
NCT00823342 ·Status: TERMINATED ·Phase: PHASE3
-
An Open Study to Evaluate the Sustained Effect in Patients Showing Virological Responses With Muscle-related Symptom of Chronic Hepatitis B Patients Who Received Clevudine
NCT01264107 ·Status: COMPLETED
-
A Pilot Study to Evaluate the Safety and Efficacy of Clevudine or Adefovir Patients With LC-B
NCT00672867 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of LW231 to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers and Participants With Chronic Hepatitis B Virus Infection
NCT06311734 ·Status: COMPLETED ·Phase: PHASE1
-
Long-term Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B
NCT01242787 ·Status: UNKNOWN ·Phase: PHASE2
-
Trial of Lamivudine Treatment in HBeAg Negative Chronic Hepatitis B Patients (in Asia)
NCT00338780 ·Status: COMPLETED ·Phase: PHASE4
-
Compare the Efficacy and Safety of 48-week Treatment With Clevudine 30mg Versus Lamivudine 100mg for CHB Infection
NCT00362635 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Bulevirtide (BLV) Therapy in HDV Chronic Hepatitis (CHD) in Italy
NCT05962307 ·Status: COMPLETED
-
A Study to Compare and Evaluate Intrahepatic cccDNA Reduction After Administrating Clevudine or Entecavir in the Chronic HBV Patients
NCT01266005 ·Status: TERMINATED ·Phase: PHASE4
-
An Study of Efficacy and Safety of Clevudine
NCT01192854 ·Status: COMPLETED ·Phase: PHASE3
-
A Platform Study to Evaluate Investigational Therapies in Chronic Hepatitis B Infection
NCT05612581 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of Dual-plasmid Hepatitis B Virus DNA Vaccine in Chronic Hepatitis B Patients
NCT01487876 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of LW231 in Participants With Chronic Hepatitis B
NCT07179575 ·Status: RECRUITING ·Phase: PHASE1/PHASE2